Best stock for Year 2005 - read the story and you will see for yourself.
Get WWBP First Thing Monday, This Is Going To Explode next 2-3 days!!!
Date: 10 Oct 2005
Company: Worldwide Biotech & Pharmaceutical Company
Current Price: $1.93
1 Week Target: $3 - $4
About Worldwide Biotech & Pharmaceutical Company
Worldwide Biotech & Pharmaceutical Co. ("WWBP") is a hi-tech biotech company
with top-ranking pharmaceutical R&D abilities, Good Manufacturing Practices (GMP)
licensed manufacturing facilities and a well-established marketing network
in China and Southeast Asia. The product range of WWBP covers Hepatitis C Virus (HCV)
products, diagnostic medicines and Over-The-Counter (OTC) drugs.
WWBP currently possesses 35,940 square meters of land and 5,359 square meters
of GMP standard facilities. With strong pharmaceutical R&D abilities especially
in the HCV field, WWBP has been known as the first biotech company in the world
to hold the technology of culturing intact HCV in vitro by cell culture.
WWBP has achieved a GMP production scale level of 10,000 ml for concentrated
HCV material and 10 grams HCV antigen per month, which is expected
to bring WWBP considerable gross sale revenue each year and greatly strengthen
the company's R&D on anti-HCV drug screen and HCV human vaccine.
WWBP had successfully reached two Memoriam of Understanding of Merger Agreements
with pharmaceutical companies in China, all of which have scalable production
and well-established sales networks, and the acquiring is expected
to be finished before the end of September 2005. The acquisitions will strengthen
WWBP's R&D abilities and production scale, as well as extend its marketing network
throughout China and Southeast Asia. WWBP has been working closely
with pharmaceutical research institutes, and has established connections
with both central & local governments.
When this Stock moves - WATCH OUT! This is your chance to get in
while it is still low. Big watch in play this Monday morning!
Put WWBP on your radar's now.
Get latest updates about Open Source Projects, Conferences and News.